Board member since 2024. Mats has a solid experience from the financial markets, mainly focused on the life science sector as an analyst and in corporate finance.

He is CEO and board member of the company Vixco Capital AB as well as board member of Arcoma AB, Arcoma Incentive AB, Herantis Pharma Oyj, FluoGuide A/S and Xbrane Biopharma AB as well as deputy board member of Eggelbertus Holding AB.

Mats Thorén has previously been a board member of C-RAD AB and also in Nalka Life Science AB.

Holdings in C-RAD: 0.